dna testing heritage

Pancreatic cancer drug-sensitivity predicted by synergy of p53-Activator Wnt Inhibitor-2 (PAWI-2) and protein biomarker expression

Pancreatic cancer drug-sensitivity predicted by synergy of p53-Activator Wnt Inhibitor-2 (PAWI-2) and protein biomarker expression

Today, pancreatic cancer (PC) is a serious well being downside within the United States. It stays a problem to develop efficacious clinically helpful PC therapies. New avenues, primarily based on translational approaches and progressive validated…